Rukiye Nar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rukiye Nar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Hande Şenol
Department of Biostatistics, Pamukkale University School of Medicine, Denizli, Turkey
2 shared publications - Süleyman Demir
Biochemistry Pamukkale Univercity Denizli Turkey
2 shared publications - Ahmet Çalışkan
Department of Medical Microbiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
1 shared publication - Aslı Bozdemir
Division of Hematology, Pamukkale University Hospital, Denizli 20070, Türkiye
1 shared publication - Aydın Demiray
Department of Medical Genetics, Faculty of Medicine, Pamukkale University, Denizli, Turkey
1 shared publication - Başak ÜNVER KOLUMAN
Pamukkale University, School of Medicine
1 shared publication
Latest Publications
- 28 April 2025
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 73 (6) , 504-513
Serum Talin-1 and Pentraxin-3 levels as biomarkers for vulnerable plaques in STEMI: Correlation with SYNTAX and Gensini scores
Cardiovascular diseases, especially ischemic heart diseases, are the leading cause of death globally, highlighting the need for improved diagnostic tools for vulnerable plaques. This study aimed to evaluate the potential of soluble Talin-1 (sTalin-1) and Pentraxin-3 (PTX-3) as biomarkers in patients with ST-elevation myocardial infarction (STEMI). Conducted as a single-center observational study, it included 40 STEMI patients and 30 controls with normal coronary arteries. Serum levels of sTalin-1 and PTX-3 were measured using enzyme-linked immunosorbent assays (ELISA), and disease severity was assessed with SYNTAX and Gensini scores. Results showed that STEMI patients had significantly lower levels of sTalin-1 and higher levels of PTX-3 compared to controls. ROC curve analysis revealed an area under the curve (AUC) of 0.785 for sTalin-1 and 0.702 for PTX-3 in differentiating between STEMI patients and controls. While sTalin-1 demonstrated high specificity but low sensitivity, PTX-3 exhibited moderate sensitivity and specificity. Talin-1 levels negatively correlated with SYNTAX and Gensini scores, suggesting its role in assessing disease severity. These findings suggest that decreased serum levels of sTalin-1 and increased levels of PTX-3 in STEMI patients could serve as potential biomarkers for identifying vulnerable plaques and assessing disease severity. The study supports the potential use of sTalin-1 and PTX-3 in the diagnostic and prognostic evaluation of acute coronary syndromes.
- 28 April 2025
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 73 (6) , 504-513
Serum Talin-1 and Pentraxin-3 levels as biomarkers for vulnerable plaques in STEMI: Correlation with SYNTAX and Gensini scores
Cardiovascular diseases, especially ischemic heart diseases, are the leading cause of death globally, highlighting the need for improved diagnostic tools for vulnerable plaques. This study aimed to evaluate the potential of soluble Talin-1 (sTalin-1) and Pentraxin-3 (PTX-3) as biomarkers in patients with ST-elevation myocardial infarction (STEMI). Conducted as a single-center observational study, it included 40 STEMI patients and 30 controls with normal coronary arteries. Serum levels of sTalin-1 and PTX-3 were measured using enzyme-linked immunosorbent assays (ELISA), and disease severity was assessed with SYNTAX and Gensini scores. Results showed that STEMI patients had significantly lower levels of sTalin-1 and higher levels of PTX-3 compared to controls. ROC curve analysis revealed an area under the curve (AUC) of 0.785 for sTalin-1 and 0.702 for PTX-3 in differentiating between STEMI patients and controls. While sTalin-1 demonstrated high specificity but low sensitivity, PTX-3 exhibited moderate sensitivity and specificity. Talin-1 levels negatively correlated with SYNTAX and Gensini scores, suggesting its role in assessing disease severity. These findings suggest that decreased serum levels of sTalin-1 and increased levels of PTX-3 in STEMI patients could serve as potential biomarkers for identifying vulnerable plaques and assessing disease severity. The study supports the potential use of sTalin-1 and PTX-3 in the diagnostic and prognostic evaluation of acute coronary syndromes.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Comparison of Urine Drug Abuse Testing Analyzed in Glass and Plastic Tubes
Kullanımının tespiti amacıyla kullanılmaktadır. Biz bu çalışmada idrarda madde analizinde ucuz ve pratik olan plastik tüplerin cam tüplere alternatif olup olamayacağını araştırmayı amaçladık. Gereç ve Yöntem: 80 yetişkin gönüllüden alınan taze idrar örnekleri cam ve plastik tüplere aktarıldı ve örneklerde idrar bütünlük testleri çalışılarak örneklerin uygunlukları değerlendirildi. Ardından idrarda amfetaminler (AMP), benzodiazepinler (BNZ), kokain (COC), opiatlar (OPI) ve kannabinoidlerin (THC) düzeyi Roche Cobas c 501’de immünoanaliz yöntemiyle yarı kantitatif olarak ölçüldü. Testin pozitifliği için kesim değerleri; AMP> 500μg/L, BNZ> 300μg/L, COC> 150μg/L, OPI> 2000μg/L ve THC> 50μg/L olarak alındı. İdrar örneklerinin bekletilmesinin test sonucuna etkisini araştırmak için, numunelerden 32 tanesi herhangi bir koruyucu madde olmadan dört saat bekletildi ve tekrar analiz edildi. Verilerin analizinde SPSS 25.0 programı kullanıldı. Bulgular: AMP, BNZ, COC, OPI ve THC konsantrasyonlarında cam ve plastik tüpler arasında anlamlı bir fark yoktu. OPI açısından istatistiksel olarak anlamlı fark bulundu (p= 0.005) ancak OPI düzeylerindeki değişiklik klinik kararı (pozitiflik) değiştirmedi. Her iki tüpte de aynı analit ölçümüne ilişkin tüm sonuçlar arasında anlamlı yüksek korelasyon vardı (p= 0.0001). Bekletilen idrar numunelerinde (n= 32) sadece BNZ plastik tüpte istatistiksel olarak anlamlı yüksek bulundu (p= 0.037); ancak bu farklılıklar örneklerin pozitifliğini veya negatifliğini değiştirmedi ve klinik olarak anlamsızdı. Tüm testler için tüp türleri ve süre açısından örnekler karşılaştırıldığında anlamlı korelasyonlar mevcuttu (p <0.001). Sonuç: Bu çalışmanın sonucunda, kötüye kullanılan ilaçların analizinde cam tüpler yerine plastik tüplerin kullanılabileceği, oda sıcaklığında dört saat saklandıktan sonra madde konsantrasyonlarında anlamlı bir değişimin olmadığı sonucu çıkarılabilir.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Comparison of Urine Drug Abuse Testing Analyzed in Glass and Plastic Tubes
Kullanımının tespiti amacıyla kullanılmaktadır. Biz bu çalışmada idrarda madde analizinde ucuz ve pratik olan plastik tüplerin cam tüplere alternatif olup olamayacağını araştırmayı amaçladık. Gereç ve Yöntem: 80 yetişkin gönüllüden alınan taze idrar örnekleri cam ve plastik tüplere aktarıldı ve örneklerde idrar bütünlük testleri çalışılarak örneklerin uygunlukları değerlendirildi. Ardından idrarda amfetaminler (AMP), benzodiazepinler (BNZ), kokain (COC), opiatlar (OPI) ve kannabinoidlerin (THC) düzeyi Roche Cobas c 501’de immünoanaliz yöntemiyle yarı kantitatif olarak ölçüldü. Testin pozitifliği için kesim değerleri; AMP> 500μg/L, BNZ> 300μg/L, COC> 150μg/L, OPI> 2000μg/L ve THC> 50μg/L olarak alındı. İdrar örneklerinin bekletilmesinin test sonucuna etkisini araştırmak için, numunelerden 32 tanesi herhangi bir koruyucu madde olmadan dört saat bekletildi ve tekrar analiz edildi. Verilerin analizinde SPSS 25.0 programı kullanıldı. Bulgular: AMP, BNZ, COC, OPI ve THC konsantrasyonlarında cam ve plastik tüpler arasında anlamlı bir fark yoktu. OPI açısından istatistiksel olarak anlamlı fark bulundu (p= 0.005) ancak OPI düzeylerindeki değişiklik klinik kararı (pozitiflik) değiştirmedi. Her iki tüpte de aynı analit ölçümüne ilişkin tüm sonuçlar arasında anlamlı yüksek korelasyon vardı (p= 0.0001). Bekletilen idrar numunelerinde (n= 32) sadece BNZ plastik tüpte istatistiksel olarak anlamlı yüksek bulundu (p= 0.037); ancak bu farklılıklar örneklerin pozitifliğini veya negatifliğini değiştirmedi ve klinik olarak anlamsızdı. Tüm testler için tüp türleri ve süre açısından örnekler karşılaştırıldığında anlamlı korelasyonlar mevcuttu (p <0.001). Sonuç: Bu çalışmanın sonucunda, kötüye kullanılan ilaçların analizinde cam tüpler yerine plastik tüplerin kullanılabileceği, oda sıcaklığında dört saat saklandıktan sonra madde konsantrasyonlarında anlamlı bir değişimin olmadığı sonucu çıkarılabilir.
- Open Access
- 9 September 2024
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 17 (4) , 11
Controlling nutritional (CONUT) score for nutritional screening in kidney transplant recipients
Purpose: Nutrition is severely impaired in individuals with renal impairment, and transplant often ameliorates this condition. In this study, we aimed to evaluate the controlling nutritional status (CONUT) score of kidney transplant (KT) recipients. Materials and methods: Using the data from the nephrology transplant unit, we analyzed 188 patients whose data on the constituents of the CONUT score were available. We included KT individuals with at least one lymphocyte count and total cholesterol and albumin concentrations. This data has been used to calculate the CONUT score. The decrease of lymphocyte counts and total cholesterol was determined with 0, 1, 2, and 3 points, and the reduction of albumin was assigned with 0, 2, 4, and 6 points in agreement with disease severity. Patients were classified according to this score: normal, light, moderate, and severe. Results: There were 138 patients in normal, 54 in light, and three in each moderate and severe group. The CONUT score was good for regular-weight patients both before and after transplantation. All laboratory findings revealed significant differences between CONUT groups (p< 0.05). The logistic regression analysis model, including cholesterol, WBC, and calcium, showed that these three parameters have a predictive value of 80%. Conclusion: After transplantation, the number of patients in the underweight group decreased when normal weight and obesity increased. However, some patients’ nutrition was not ameliorated. The CONUT score may be a useful tool for monitoring transplant patients’ nutritional status.
- 9 September 2024
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 17 (4) , 11
Open AccessControlling nutritional (CONUT) score for nutritional screening in kidney transplant recipients
Purpose: Nutrition is severely impaired in individuals with renal impairment, and transplant often ameliorates this condition. In this study, we aimed to evaluate the controlling nutritional status (CONUT) score of kidney transplant (KT) recipients. Materials and methods: Using the data from the nephrology transplant unit, we analyzed 188 patients whose data on the constituents of the CONUT score were available. We included KT individuals with at least one lymphocyte count and total cholesterol and albumin concentrations. This data has been used to calculate the CONUT score. The decrease of lymphocyte counts and total cholesterol was determined with 0, 1, 2, and 3 points, and the reduction of albumin was assigned with 0, 2, 4, and 6 points in agreement with disease severity. Patients were classified according to this score: normal, light, moderate, and severe. Results: There were 138 patients in normal, 54 in light, and three in each moderate and severe group. The CONUT score was good for regular-weight patients both before and after transplantation. All laboratory findings revealed significant differences between CONUT groups (p< 0.05). The logistic regression analysis model, including cholesterol, WBC, and calcium, showed that these three parameters have a predictive value of 80%. Conclusion: After transplantation, the number of patients in the underweight group decreased when normal weight and obesity increased. However, some patients’ nutrition was not ameliorated. The CONUT score may be a useful tool for monitoring transplant patients’ nutritional status.
- Open Access
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 2112-2119
Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?
Background/aim: The aim of the study was to evaluate the effect of Controlling Nutritional Status (CONUT) score on the prognosis in patients with diffuse large B-cell lymphoma (DLBCL). Materials and methods: The present study was a retrospective study. The CONUT score was calculated based on serum albumin, total cholesterol and lymphocyte levels. This study included a total of 266 patients, 131 (49.2%) were female and 135 (50.8%) were male. The median follow-up period was 51 months (range: 1-190). Results: The median age was 64 years. The cut off CONUT was 1.5. There was a significant difference between patients with high (>_ 2) or low (< 2) CONUT scores in terms of overall survival (OS) and progression-free survival (PFS). The 5-year OS and PFS in patients with high CONUT score was 52.1% and 49.7%. The 5-year OS and PFS in patients with low CONUT score was 79.8% and 75.6% (p < 0.001). In the multivariate analysis for OS, age >_ 65 years (HR = 1.80, p = 0.028), Eastern Cooperative Oncology Group (ECOG) > 1 (HR = 2.04, p = 0.006), stage IIIA-IVB disease (HR = 2.75, p = 0.001) and the CONUT score (HR = 1.15, p = 0.003) were found statistically significant. In the multivariate analysis for PFS, age >_ 65 years (HR = 2.02, p = 0.007), stage IIIA-IVB disease (HR = 2.42, p = 0.002) and the CONUT score (HR = 1.19, p = 0.001) were found to be significant parameters. Conclusion: High CONUT score reduces OS and PFS in DLBCL. CONUT score is an independent, strong prognostic index in patients with DLBCL.
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 2112-2119
Open AccessIs CONUT score a prognostic index in patients with diffuse large cell lymphoma?
Background/aim: The aim of the study was to evaluate the effect of Controlling Nutritional Status (CONUT) score on the prognosis in patients with diffuse large B-cell lymphoma (DLBCL). Materials and methods: The present study was a retrospective study. The CONUT score was calculated based on serum albumin, total cholesterol and lymphocyte levels. This study included a total of 266 patients, 131 (49.2%) were female and 135 (50.8%) were male. The median follow-up period was 51 months (range: 1-190). Results: The median age was 64 years. The cut off CONUT was 1.5. There was a significant difference between patients with high (>_ 2) or low (< 2) CONUT scores in terms of overall survival (OS) and progression-free survival (PFS). The 5-year OS and PFS in patients with high CONUT score was 52.1% and 49.7%. The 5-year OS and PFS in patients with low CONUT score was 79.8% and 75.6% (p < 0.001). In the multivariate analysis for OS, age >_ 65 years (HR = 1.80, p = 0.028), Eastern Cooperative Oncology Group (ECOG) > 1 (HR = 2.04, p = 0.006), stage IIIA-IVB disease (HR = 2.75, p = 0.001) and the CONUT score (HR = 1.15, p = 0.003) were found statistically significant. In the multivariate analysis for PFS, age >_ 65 years (HR = 2.02, p = 0.007), stage IIIA-IVB disease (HR = 2.42, p = 0.002) and the CONUT score (HR = 1.19, p = 0.001) were found to be significant parameters. Conclusion: High CONUT score reduces OS and PFS in DLBCL. CONUT score is an independent, strong prognostic index in patients with DLBCL.
- Open Access
- 20 January 2021
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 46 (3) , 245-253
Serum microRNA signature is capable of predictive and prognostic factor for SARS-COV-2 virulence
Objectives: Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MicroRNAs (miRNA) are small non-coding RNAs consisting of 19–25 nucleotides and play a role in post-transcriptional gene regulation. We have focused on serum expression levels of microRNA (miRNA) a novel concept of in host–virus interactions. MicroRNA expression profiles were investigated in serum samples of COVID-19 patients. Materials and methods: The samples were collected from 40 patients diagnosed with COVID-19 patients and from 10 healthy controls. Expression profile of 20 miRNAs were examined using a quantitative real-time polymerase chain reaction (qPCR). Results: Statistically significant expression level differences (p < 0.05) were detected in nine miRNAs in COVID-19 patients and healthy controls. 7 miRNAs (hsa-let-7d, hsa-miR-17, hsa-miR-34b, hsa-miR-93, hsa-miR-200b, hsa-miR-200c, hsa-miR-223) expression levels were found to be significantly decreased and the expression levels of 2 miRNAs (hsa-miR-190a and hsa-miR-203) significantly increased respect to healthy controls. Conclusions: We expect that a miRNA profile can be beneficial for the diagnosis of the COVID-19. Our result revealed that the increase in hsa-miR-190a level may be a prognostic factor related to the COVID-19 disease.
- 20 January 2021
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 46 (3) , 245-253
Open AccessSerum microRNA signature is capable of predictive and prognostic factor for SARS-COV-2 virulence
Objectives: Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MicroRNAs (miRNA) are small non-coding RNAs consisting of 19–25 nucleotides and play a role in post-transcriptional gene regulation. We have focused on serum expression levels of microRNA (miRNA) a novel concept of in host–virus interactions. MicroRNA expression profiles were investigated in serum samples of COVID-19 patients. Materials and methods: The samples were collected from 40 patients diagnosed with COVID-19 patients and from 10 healthy controls. Expression profile of 20 miRNAs were examined using a quantitative real-time polymerase chain reaction (qPCR). Results: Statistically significant expression level differences (p < 0.05) were detected in nine miRNAs in COVID-19 patients and healthy controls. 7 miRNAs (hsa-let-7d, hsa-miR-17, hsa-miR-34b, hsa-miR-93, hsa-miR-200b, hsa-miR-200c, hsa-miR-223) expression levels were found to be significantly decreased and the expression levels of 2 miRNAs (hsa-miR-190a and hsa-miR-203) significantly increased respect to healthy controls. Conclusions: We expect that a miRNA profile can be beneficial for the diagnosis of the COVID-19. Our result revealed that the increase in hsa-miR-190a level may be a prognostic factor related to the COVID-19 disease.
- Open Access
- 1 December 2019
- Published by Modestum Ltd in Ortadoğu Tıp Dergisi
- Vol. 11 (4) , 396-403
Evaluation of thiol-disulphide homeostasis in patients with chronic hepatitis B
- 1 December 2019
- Published by Modestum Ltd in Ortadoğu Tıp Dergisi
- Vol. 11 (4) , 396-403
Open AccessEvaluation of thiol-disulphide homeostasis in patients with chronic hepatitis B
- Open Access
- 1 January 2019
- Published by Kare Publishing in International Journal of Medical Biochemistry
Evaluation of Vitamin D Status and Its Association with Thyroid Disease
- 1 January 2019
- Published by Kare Publishing in International Journal of Medical Biochemistry
Open AccessEvaluation of Vitamin D Status and Its Association with Thyroid Disease